Skip to main content
NCBI home page
Pharmaceuticals logoLink to Pharmaceuticals
. 2025 Nov 20;18(11):1763. doi: 10.3390/ph18111763

RETRACTED: Rajkhowa et al. Activating SIRT-1 Signalling with the Mitochondrial-CoQ10 Activator Solanesol Improves Neurobehavioral and Neurochemical Defects in Ouabain-Induced Experimental Model of Bipolar Disorder. Pharmaceuticals 2022, 15, 959

Bidisha Rajkhowa 1, Sidharth Mehan 1,*, Pranshul Sethi 1, Aradhana Prajapati 1, Manisha Suri 1, Sumit Kumar 1, Sonalika Bhalla 1, Acharan S Narula 2, Abdulrahman Alshammari 3, Metab Alharbi 3, Nora Alkahtani 3, Saeed Alghamdi 3, Reni Kalfin 4,5
PMCID: PMC12655513  PMID: 41305017

The journal retracts the article “Activating SIRT-1 Signalling with the Mitochondrial-CoQ10 Activator Solanesol Improves Neurobehavioral and Neurochemical Defects in Ouabain-Induced Experimental Model of Bipolar Disorder” [1] cited above.

Following publication, concerns were brought to the attention of the Editorial Office regarding the integrity of images presented in this publication [1].

Adhering to our standard procedure, the Editorial Office and Editorial Board carried out an investigation that identified partial duplication between sub-images of Figure 12 published in [1], presenting different experimental conditions. While the authors collaborated within this process, the Editorial Board has lost confidence in the reliability of the findings and has decided to retract this publication, as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30).

This retraction was approved by the Editor-in-Chief of the journal Pharmaceuticals.

The authors disagree with this decision.

Footnotes

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Reference

  • 1.Rajkhowa B., Mehan S., Sethi P., Prajapati A., Suri M., Kumar S., Bhalla S., Narula A.S., Alshammari A., Alharbi M., et al. RETRACTED: Activating SIRT-1 Signalling with the Mitochondrial-CoQ10 Activator Solanesol Improves Neurobehavioral and Neurochemical Defects in Ouabain-Induced Experimental Model of Bipolar Disorder. Pharmaceuticals. 2022;15:959. doi: 10.3390/ph15080959. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from Pharmaceuticals are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES